ARA named radiopharmaceutical 'center of excellence'
September 14, 2022 -- The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has certified ARA Diagnostic Imaging's ARA Theranostics Center as a radiopharmaceutical therapy center of excellence. Read More
ASRT: Radiation therapist vacancy rates have increased
September 12, 2022 -- Radiation therapist vacancy rates have increased by more than 10% in 2022, according to the American Society of Radiologic Technologists (ASRT). Read More
SNMMI names Hoag to be a radiopharmaceutical 'center of excellence'
September 12, 2022 -- The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has named Hoag Memorial Hospital Presbyterian in Newport Beach, CA, as a radiopharmaceutical therapy center of excellence. Read More
Health Canada approves Pluvicto for prostate cancer treatment
September 8, 2022 -- Health Canada has approved lutetium-177 prostate-specific membrane antigen radioligand therapy (Pluvicto, Novartis) for the treatment of patients with metastatic prostate cancer. Read More
ViewRay's radiation therapy system can be sold in China
September 7, 2022 -- Image-guided radiation therapy vendor ViewRay's MRIdian MRI-guided radiation therapy system now can be sold and used in China. Read More
IBA reports revenue increase in first half of 2022
September 1, 2022 -- Proton therapy developer Ion Beam Applications (IBA) reported an increase in total revenue for the first half of 2022, despite the fact that its backlog of sales is still impacted by the COVID-19 pandemic. Read More
ASTRO issues guide on radiation therapy for glioma
August 31, 2022 -- The American Society for Radiation Oncology (ASTRO) has issued a guide on the use of radiation therapy in adults with isocitrate dehydrogenase-mutant grade 2 and grade 3 diffuse glioma. Read More
IBA to collaborate with ScandiDos
August 31, 2022 -- Proton therapy developer Ion Beam Applications (IBA) and Swedish radiation therapy quality assurance firm ScandiDos will work together on integrating their radiation therapy dosimetry offerings. Read More
RaySearch posts mixed results in Q2
August 30, 2022 -- Radiation therapy software developer RaySearch Laboratories produced a 3.6% increase in revenue and a slightly higher loss after tax in its second quarter. Read More
First patient in Oncoinvent trial treated for colorectal cancer
August 26, 2022 -- Norwegian radiopharmaceutical developer Oncoinvent is highlighting that the first colorectal cancer patient has been treated in a clinical trial of the company's Radspherin drug candidate. Read More
Special Feature
Representation in radiation oncology remains challenging
Radiation oncology has some of the lowest numbers when it comes to female senior faculty representation, according to research published in JAMA Network Open. Read more
VENDOR CONNECT